Food and Drug Administration

Oct 30

Reason for Hope and VMHLC Provide Comments to Reagan-Udall Foundation for the FDA on Advancing Treatment for PTSD

Following the September 6, 2024 public meeting hosted by the Reagan-Udall Foundation for the FDA in which agency officials joined...

Aug 9

Reason for Hope and the Veteran Mental Health Leadership Coalition Issue Statement on FDA Denying MDMA-Assisted Therapy for PTSD

August 09, 2024 (NEW YORK) – Reason for Hope and its member organization, the V eteran Mental Health Leadership Coalition , issued...

Aug 3

Reason for Hope and VMHLC join other veterans groups in letter to Biden Administration in support of FDA approval for MDMA-AT for PTSD.

Reason for Hope and VMHLC joined twelve other veteran service organizations and veterans groups in a letter to the Biden Administration...

Jun 10

Reason for Hope & VMHLC submit comments for MDMA drug application to FDA advisory committee

Reason for Hope and VMHLC submit comments to FDA advisory committee on MDMA drug application

Jun 9

Lt. General Martin R. Steele, US Marine Corps (Ret.) on Advisory Panel of FDA Rejecting MDMA-Assisted Therapy for PTSD

Reason for Hope and VMHLC express disappointment with FDA Advisory Committee's recommendations for MDMA drug application.

Aug 24, 2023

Reason for Hope, et al. Provide Comments on FDA Draft Guidance for Clinical Investigation of Psychedelic Drugs

Reason for Hope, The Veteran Mental Health Leadership Coalition, BrainFutures, and the additional cosigners noted below provided comments...